Cefaly® offers the best safety efficacy ratio compared to current anti-migraine oral medication. It is the first line treatment for patients having frequent migraine attacks. Cefaly enables the use of medicines to be significantly reduced and the sufferer's quality of life to be markedly improved. It is the solution for most of migraineurs. Cefaly bears the CE Medical mark, is certified to the ISO Medical standard.
Cefaly Dual Migraine treatment device uses electric impulses that are delivered to the main branch of the trigeminal nerve to prevent and treat pain in the head area. This method can replace or considerably reduce the consumption of painkilling medication and helps to find a better quality of life.
In clinical trials, 81% of compliant patients show a significant reduction of migraine attacks
and were very satisfied with the Cefaly® treatment. There was up to a 75% reduction in
consumption of migraine medications for these patients. Cefaly® offers the best safety-effectiveness ratio compared to current anti-migraine oral medication and is now the first line treatment for patients having very frequent migraine attacks.
For more info visit https://www.cefaly.co.uk/en